Samlyn Capital, LLC Seagen Inc. Transaction History

Samlyn Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $239,382 - $394,526	2,200 Added 0.29%	770,764 $136 Million
Q1 2022 May 16, 2022	BUY	$119.61 - $157.85 $26.3 Million - $34.7 Million	219,941 Added 40.09%	768,564 $111 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $11.9 Million - $16 Million	83,763 Added 18.02%	548,623 $84.8 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $29.4 Million - $35 Million	206,277 Added 79.77%	464,860 $78.9 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $34.9 Million - $41.7 Million	258,583 New	258,583 $40.8 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Samlyn Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samlyn Capital, LLC with notifications on news.